Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001949:Bretylium Compounds / Q000627:therapeutic use*; D001950:Bretylium Tosylate / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*
D001949:Bretylium Compounds; D001950:Bretylium Tosylate